Fennec Pharmaceuticals' future growth is expected to be lowe...
Fennec Pharmaceuticals' future growth is expected to be lower than the industry average, not reflected in its P/S ratio. This could lead to investor disappointment if the P/S ratio adjusts to match the growth outlook.
Revenues Not Telling The Story For Fennec Pharmaceuticals Inc. (NASDAQ:FENC) After Shares Rise 26%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment